Eurican L4 Suspension for Injection

Indications for use, specifying the target species:

Active immunisation of dogs from 7 weeks of age to prevent or reducemortality, clinical signs, infection, bacterial excretion, renal carriage and renal lesions caused by:
- Leptospira interrogans serogroup Canicola serovar Canicola,
- Leptospira interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae,
- Leptospira kirschneri serogroup Grippotyphosa serovar Grippotyphosa, and
- Leptospira interrogans serogroup Australis serovar Bratislava.

* For Leptospira interrogans serovar Canicola, no mortality and clinical signs occurred in the vaccinated and control groups during challenge experiment for duration of immunity.
**For Leptospira interrogans serovar Icterohaemorrhagiae and Leptospira kirschneri serovar Grippotyphosa, no mortality occurred in the vaccinated and control groups during challenge experiments for duration of immunity and the prevention of clinical signs was not statistically significant.

Onset of immunity: 2 weeks after the second injection of the primary vaccination course for all strains.
Duration of immunity: at least one year after the second injection of the primary vaccination course for all strains.